C00021916

[PAGE 2]
MEMORANDUM FOR THE RECORD

BUBJECT: Meeting with of the Bureau of Narcotics and Dangerous Drugs

1. On 8 April 1968, Reorganization Plan 1 of 1968 transferred the Bureau of Narcotics from the Department of the Treasury and the. Bureau of Drug Abuse Control from the Department of Health, Educetion, and Welfare to the Department of Justice and created the Bureau of

. Earcotics and Dangerous Drugs under the direction of Within the new bureau, lis Chief of Intelligence, Dr. is Chief of Laboratory Operations in the Office of Science and Education and is Chief of the Organized Crime Division. ja previous Agency employee on the Staff, holds a Top Secret Agency clearance. Mr. Jnd Dr. are ex-employees of the FEI and hold Secret Agency clearances..

2. In order to. gain perspective on the nev buresu's operations, Drs. met with the above named iniividuals in Mr. Jon 19 March 1969. The general discussion that foiloved revealed that:

e. Clendestin? drug mamufacturing is rather extensive with BNDD Agents having broken up 42 clandestiue operations as of 1 year ago, 36 of these making ballucinogens.

b. Principal ethical sources of LSD at this time are land The are sensitive to the illicite use problem

C00021916.

b2,65

114

24 March 19€9.

This is being remedied and they expect grenter efficiency will result.

[PAGE 3]
Page 2

d. Analytical methods for detection and identirication of drugs are constantly under study and review vith emphasis \techniques. Also, current funding may include research at

3o.At this point, Drs. described very briefly the Agency's interest in behavioral agents, emphasizing the need to maintain constant surveillance of developments in this area and to provide s protective shield against potential hostile employment of these agents on U.S. officials. Also, the need for strict security concerning Agency interest in this area was especially emphasized. Mr. assured us that the matter would be held very closely within the group present with the exception of the Director, who would be informed that the meeting had taken place.

4. It was sgreed that future leason would be handled through Dr. and that such cooperation would include periodic briefings on new developments at ENDD.

5. It appears thet the activities of anD, on-going and planned, could under the appropriate arrangements provide valuable information to the Agency in new drug effects, drug abuse and drug traffic areas. For this reason they vill be followed very closely.

C00021916'